These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 30347513)

  • 1. Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease.
    Paik J; Golabi P; Younoszai Z; Mishra A; Trimble G; Younossi ZM
    Liver Int; 2019 Feb; 39(2):342-352. PubMed ID: 30347513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAFLD and risk of CKD.
    Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
    Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
    Park H; Dawwas GK; Liu X; Nguyen MH
    J Intern Med; 2019 Dec; 286(6):711-722. PubMed ID: 31359543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
    Chinnadurai R; Chrysochou C; Kalra PA
    Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
    Golabi P; Paik J; Reddy R; Bugianesi E; Trimble G; Younossi ZM
    BMC Gastroenterol; 2019 Apr; 19(1):56. PubMed ID: 30991959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016.
    Golabi P; Paik JM; Harring M; Younossi E; Kabbara K; Younossi ZM
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2838-2847.e7. PubMed ID: 34929391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).
    Golabi P; Otgonsuren M; de Avila L; Sayiner M; Rafiq N; Younossi ZM
    Medicine (Baltimore); 2018 Mar; 97(13):e0214. PubMed ID: 29595666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States.
    Wijarnpreecha K; Scribani M; Kim D; Kim WR
    Liver Int; 2019 Jul; 39(7):1202-1206. PubMed ID: 30697898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease-related advanced fibrosis.
    Kim D; Li AA; Ahmed A
    Liver Int; 2018 Oct; 38(10):1839-1848. PubMed ID: 29797393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.
    Younossi ZM; Stepanova M; Ong J; Yilmaz Y; Duseja A; Eguchi Y; El Kassas M; Castellanos-Fernandez M; George J; Jacobson IM; Bugianesi E; Wong VW; Arrese M; de Ledinghen V; Romero-Gomez M; Mendez-Sanchez N; Ahmed A; Wong R; Papatheodoridis G; Serfaty L; Younossi I; Nader F; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1625-1633.e1. PubMed ID: 30476585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.
    Stepanova M; Younossi ZM
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):646-50. PubMed ID: 22245962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
    Hwang YC; Ahn HY; Park SW; Park CY
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
    Angulo P; Kleiner DE; Dam-Larsen S; Adams LA; Bjornsson ES; Charatcharoenwitthaya P; Mills PR; Keach JC; Lafferty HD; Stahler A; Haflidadottir S; Bendtsen F
    Gastroenterology; 2015 Aug; 149(2):389-97.e10. PubMed ID: 25935633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrahepatic Complications of Nonalcoholic Fatty Liver Disease.
    Chacko KR; Reinus J
    Clin Liver Dis; 2016 May; 20(2):387-401. PubMed ID: 27063276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression is associated with non-alcoholic fatty liver disease among adults in the United States.
    Kim D; Yoo ER; Li AA; Tighe SP; Cholankeril G; Harrison SA; Ahmed A
    Aliment Pharmacol Ther; 2019 Sep; 50(5):590-598. PubMed ID: 31328300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.